<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Crit Care</journal-id><journal-id journal-id-type="iso-abbrev">Crit Care</journal-id><journal-title-group><journal-title>Critical Care</journal-title></journal-title-group><issn pub-type="ppub">1364-8535</issn><issn pub-type="epub">1466-609X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">3333350</article-id><article-id pub-id-type="publisher-id">cc1230</article-id><article-id pub-id-type="doi">10.1186/cc1230</article-id><article-categories><subj-group subj-group-type="heading"><subject>Meeting Abstract</subject></subj-group></article-categories><title-group><article-title>Early stenting vs conservative treatment after thrombolysis in acute myocardial infarction: results of a randomized trial</article-title></title-group><contrib-group><contrib contrib-type="author" id="A1"><name><surname>Hammer</surname><given-names>B</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A2"><name><surname>Scheller</surname><given-names>B</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>B&#x000f6;hm</surname><given-names>M</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Hennen</surname><given-names>B</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib></contrib-group><aff id="I1"><label>1</label>Internal Medicine III (Cardiology/Angiology), University of Saarland, D-66421 Homburg/Saar, Germany</aff><pub-date pub-type="ppub"><year>2001</year></pub-date><pub-date pub-type="epub"><day>2</day><month>3</month><year>2001</year></pub-date><volume>5</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">21st International Symposium on Intensive Care and Emergency Medicine</named-content></supplement><fpage>P163</fpage><lpage>P163</lpage><history><date date-type="received"><day>15</day><month>1</month><year>2001</year></date></history><self-uri xlink:href="http://ccforum.com/content/5/S1/P163"/><conference><conf-date>20-23 March 2001</conf-date><conf-name>21st International Symposium on Intensive Care and Emergency Medicine</conf-name><conf-loc>Brussels, Belgium</conf-loc></conference></article-meta></front><body><sec><title/><p>Thrombolysis (T) in acute myocardial infarction (AMI) is limited by TIMI III-flow rates of 60% and reocclusion of the infarct related artery in 5 to 10%. Prior studies showed no benefit of PTCA following T in AMI. Recent studies have demonstrated superiority of primary stenting versus PTCA alone in AMI.</p><p>We are conducting a multicenter, randomized, prospective, controlled trial to compare the strategy of early coronary stenting (group A) with conservative treatment (group B) following T within 12 hours after onset of AMI. Patients of group A are transferred to the interventional center within 6 hours after T for coronary angiography including stenting of the infarct related artery. Group B has elective coronary angiography after 2 weeks. Primary endpoint is a combined endpoint of death, reinfarction, and target lesion revascularization.</p><p>So far (November 2000) 176 pts have been randomized. There are no significant differences regarding sex, age, infarct localization, risk factors, ck-elevation and cardiogenic shock. Mean follow-up time is 158 &#x000b1; 97 days.</p></sec><sec><title>Results</title><table-wrap id="T1" position="float"><label>Table 1</label><table frame="hsides" rules="groups"><thead><tr><th/><th align="center">Group A</th><th align="center">Group B</th><th/></tr><tr><th/><th align="center">(<italic>n</italic> = 71)</th><th align="center">(<italic>n</italic> = 75)</th><th align="center"><italic>P</italic> value</th></tr></thead><tbody><tr><td align="left">Combined end point</td><td align="center">22.5%</td><td align="center">37.3%</td><td align="center">0.038</td></tr><tr><td align="left">Death</td><td align="center">5.6%</td><td align="center">10.7%</td><td align="center">ns</td></tr><tr><td align="left">Reinfarction</td><td align="center">2.8%</td><td align="center">2.7%</td><td align="center">ns</td></tr><tr><td align="left">Target lesion revascularization</td><td align="center">16.9%</td><td align="center">25.3%</td><td align="center">ns</td></tr></tbody></table></table-wrap><p>Bleeding complications occurred in 11% of pts in group I vs 8% in group II (ns).</p></sec><sec><title>Conclusion</title><p>Early stenting after T in AMI is safe. This preliminary data indicate a clinical benefit by this approach compared to conservative treatment after T in AMI.</p></sec></body></article>